GOLDSMITH MARK A bought RVMD
March 2, 2026 · Form 4 insider transaction
GOLDSMITH MARK A bought 30,000 shares of Revolution Medicines, Inc. at $4.09 per share, a transaction worth $122.7K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
30,000
Price
$4.09
Total value
$122.7K
InsiderGOLDSMITH MARK A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 2, 2026
Filing dateMarch 3, 2026
Shares owned after319,569
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024.; Includes 225,863 restricted stock units.